相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Agreement between L1 and E6/E7-based assays for detection of high-risk HPV in cervical, oropharyngeal and penile cancers
Elia Alcaniz Boada et al.
JOURNAL OF CLINICAL PATHOLOGY (2023)
Metadta: a Stata command for meta-analysis and meta-regression of diagnostic test accuracy data - a tutorial
Victoria Nyawira Nyaga et al.
ARCHIVES OF PUBLIC HEALTH (2022)
The European response to theWHOcall to eliminate cervical cancer as a public health problem
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
Marc Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: a randomised controlled trial
Caroline Hellsten et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2021)
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Manuel Zorzi et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Commercially available molecular tests for human papillomaviruses: a global overview
M. Poljak et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri
Ola Forslund et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening
Hye-Young Wang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay
Christer Borgfeldt et al.
JOURNAL OF VIROLOGICAL METHODS (2019)
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement
Matthew D. F. McInnes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples
Katrin Christine Asciutto et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
High-risk HPV-RNA screening of physician- and self-collected specimens for detection of cervical lesions among female sex workers in Nairobi, Kenya
Virginia Senkomago et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
M. Arbyn et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial
Darrel A. Cook et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer
V. Senkomago et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
A review of the clinical performance of the Aptima HPV assay
Juliane Haedicke et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
Matejka Rebolj et al.
PLOS ONE (2016)
Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening Baseline and Longitudinal Results From the CLEAR Study
Jennifer L. Reid et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn et al.
LANCET ONCOLOGY (2014)
Evaluation of a New APTIMA Specimen Collection and Transportation Kit for High-Risk Human Papillomavirus E6/E7 Messenger RNA in Cervical and Vaginal Samples
Max Chernesky et al.
SEXUALLY TRANSMITTED DISEASES (2014)
Comparing the performance of six human papillomavirus tests in a screening population
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2013)
Triage of Women With Minor Abnormal Cervical Cytology
Freija Verdoodt et al.
CANCER CYTOPATHOLOGY (2013)
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection
Lucybeth Nieves et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
D. A. M. Heideman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar et al.
VACCINE (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA
Gerald Coquillard et al.
GYNECOLOGIC ONCOLOGY (2011)
Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study
Joseph Monsonego et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer
Samuel Ratnam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo
S. Hovland et al.
BRITISH JOURNAL OF CANCER (2010)
Nucleic Acid Sequence-Based Amplification Assay for Human Papillomavirus mRNA Detection and Typing: Evidence for DNA Amplification
Gaelle A. V. Boulet et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets
Damon Getman et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
The binomial distribution of meta-analysis was preferred to model within-study variability
Taye H. Hamza et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Human papillomavirus genotype specificity of Hybrid Capture 2
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
metan: fixed- and random-effects meta-analysis
Ross J. Harris et al.
STATA JOURNAL (2008)
Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach
Haitao Chu et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
